Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
33,249,489
-
Share change
-
-1,472,596
-
Total reported value
-
$963,158,808
-
Put/Call ratio
-
56%
-
Price per share
-
$28.99
-
Number of holders
-
240
-
Value change
-
-$63,190,016
-
Number of buys
-
111
-
Number of sells
-
142
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2025
As of 31 Mar 2025,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,249,489 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TD Asset Management Inc, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, FULLER & THALER ASSET MANAGEMENT, INC., Epoch Investment Partners, Inc., Boston Trust Walden Corp, MARSHALL WACE, LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.